0001493152-21-015592.txt : 20210629 0001493152-21-015592.hdr.sgml : 20210629 20210629172059 ACCESSION NUMBER: 0001493152-21-015592 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210629 DATE AS OF CHANGE: 20210629 EFFECTIVENESS DATE: 20210629 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RESQ PHARMACEUTICALS INC. CENTRAL INDEX KEY: 0001805243 IRS NUMBER: 833795334 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-404660 FILM NUMBER: 211059211 BUSINESS ADDRESS: STREET 1: 59-780 KAPUHI PLACE CITY: HALEIWA STATE: HI ZIP: 96712 BUSINESS PHONE: 9493713993 MAIL ADDRESS: STREET 1: 59-780 KAPUHI PLACE CITY: HALEIWA STATE: HI ZIP: 96712 D 1 primary_doc.xml X0708 D LIVE 0001805243 RESQ PHARMACEUTICALS INC. 3535 EXECUTIVE TERMINAL DRIVE SUITE 110 HENDERSON NV NEVADA 89052 (701) 541-9222 DELAWARE None None Corporation true 2019 BEN ESQUE 3535 EXECUTIVE TERMINAL DRIVE SUITE 110 HENDERSON NV NEVADA 89052 Executive Officer Director Pharmaceuticals Decline to Disclose 06b false 2021-06-14 false true false 0 None None None None NONE NONE NONE XX Unknown None AZ ARIZONA CA CALIFORNIA CO COLORADO HI HAWAII IL ILLINOIS MI MICHIGAN NE NEBRASKA NV NEVADA SC SOUTH CAROLINA TN TENNESSEE TX TEXAS WA WASHINGTON false 10000000 8804985 1195015 false 52 0 0 9950000 true false RESQ PHARMACEUTICALS INC. /s/ Ben Esque Ben Esque Chief Executive Officer 2021-06-29